Drexel H, Rein P, Hostalek U, Kastelein J Clinical Experience With Prolonged-Release Nicotinic Acid in Statin-Treated Patients Managed in the Usual-Care Setting in Austria: An Analysis from Niaspan®-Induced HDL-Elevation for Optimizing Risk Control (NEMO) Study Journal of Clinical and Basic Cardiology 2007; 10 (1-4): 7-10 PDF Summary Overview
| ||||
Figure/Graphic 1: NEMO study Incidences of flushing during the NEMO study. Percentages refer to overall populations (n = 220 for the Austrian population and n = 1053 for the overall population). The severity of flushes was rated by study investigators. |
![]()
Figure/Graphic 1: NEMO study
Incidences of flushing during the NEMO study. Percentages refer to overall populations (n = 220 for the Austrian population and n = 1053 for the overall population). The severity of flushes was rated by study investigators. |